Jorey Chernett Purchases 40,000 Shares of AirSculpt Technologies (NASDAQ:AIRS) Stock

AirSculpt Technologies, Inc. (NASDAQ:AIRS) major shareholder Jorey Chernett bought 40,000 shares of the business’s stock in a transaction on Friday, April 17th. The shares were purchased at an average cost of $2.54 per share, for a total transaction of $101,600.00. Following the completion of the purchase, the insider owned 7,053,761 shares in the company, valued at approximately $17,916,552.94. This trade represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Large shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Jorey Chernett also recently made the following trade(s):

• On Tuesday, April 14th, Jorey Chernett purchased 20,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.60 per share, for a total transaction of $52,000.00.
• On Tuesday, April 7th, Jorey Chernett purchased 60,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.93 per share, for a total transaction of $175,800.00.
• On Friday, April 3rd, Jorey Chernett purchased 90,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.82 per share, for a total transaction of $253,800.00.
• On Monday, March 23rd, Jorey Chernett purchased 50,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.91 per share, for a total transaction of $145,500.00.
• On Friday, March 20th, Jorey Chernett purchased 40,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.77 per share, for a total transaction of $110,800.00.
• On Thursday, March 19th, Jorey Chernett purchased 77,702 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.64 per share, for a total transaction of $205,133.28.
• On Tuesday, March 17th, Jorey Chernett purchased 83,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.56 per share, for a total transaction of $212,480.00.
• On Monday, March 16th, Jorey Chernett purchased 105,848 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.43 per share, for a total transaction of $257,210.64.
• On Wednesday, March 11th, Jorey Chernett purchased 88,000 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.15 per share, for a total transaction of $189,200.00.
• On Friday, March 6th, Jorey Chernett purchased 45,600 shares of AirSculpt Technologies stock. The stock was bought at an average cost of $2.00 per share, for a total transaction of $91,200.00.

AirSculpt Technologies Trading Down 7.2%

NASDAQ AIRS opened at $2.45 on Wednesday. AirSculpt Technologies, Inc. has a 1-year low of $1.51 and a 1-year high of $12.00. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $172.84 million, a PE ratio of -12.89 and a beta of 2.22. The firm’s fifty day simple moving average is $2.38 and its 200-day simple moving average is $3.95.

AirSculpt Technologies (NASDAQ:AIRS) last posted its quarterly earnings results on Tuesday, March 31st. The company reported $0.02 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.03) by $0.05. AirSculpt Technologies had a negative net margin of 7.68% and a negative return on equity of 5.01%. The business had revenue of $33.44 million for the quarter, compared to the consensus estimate of $34.93 million. During the same period in the prior year, the business posted ($0.09) earnings per share. AirSculpt Technologies’s revenue for the quarter was down 14.8% compared to the same quarter last year. As a group, sell-side analysts anticipate that AirSculpt Technologies, Inc. will post -0.06 earnings per share for the current fiscal year.

Institutional Investors Weigh In On AirSculpt Technologies

A number of large investors have recently bought and sold shares of AIRS. Invesco Ltd. bought a new stake in AirSculpt Technologies in the first quarter worth $56,000. Creative Planning boosted its holdings in AirSculpt Technologies by 32.2% during the second quarter. Creative Planning now owns 13,225 shares of the company’s stock valued at $64,000 after acquiring an additional 3,224 shares during the period. WINTON GROUP Ltd bought a new stake in AirSculpt Technologies during the second quarter valued at about $106,000. Jane Street Group LLC bought a new stake in AirSculpt Technologies during the second quarter valued at about $60,000. Finally, Balyasny Asset Management L.P. boosted its holdings in AirSculpt Technologies by 128.5% during the second quarter. Balyasny Asset Management L.P. now owns 1,113,843 shares of the company’s stock valued at $5,380,000 after acquiring an additional 626,309 shares during the period. 91.54% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the stock. Wall Street Zen raised shares of AirSculpt Technologies from a “sell” rating to a “hold” rating in a research note on Sunday, April 5th. Weiss Ratings reiterated a “sell (d-)” rating on shares of AirSculpt Technologies in a report on Monday, December 29th. One analyst has rated the stock with a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Reduce” and an average price target of $6.00.

About AirSculpt Technologies

AirSculpt Technologies, Inc (NASDAQ: AIRS) is a medical technology company specializing in minimally invasive body contouring. The company’s flagship AirSculpt® platform combines pneumatic power with precision microcannulas to deliver fat removal, transfer and sculpting procedures. AirSculpt Technologies partners with both company-owned and franchised cosmetic surgery practices to offer a streamlined, office-based alternative to traditional liposuction.

Through its proprietary system, AirSculpt Technologies provides both consumers and medical professionals with an integrated solution that emphasizes reduced downtime, smaller incision sites, and more predictable outcomes.